Navigation Links
Reportlinker Adds Downstream Processing in Biopharmaceuticals - Increased Demand for Biologics Drives Improvement in Cost -effective Purification Technologies
Date:10/19/2010

NEW YORK, Oct. 19 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Downstream Processing in Biopharmaceuticals - Increased Demand for Biologics Drives Improvement in Cost -effective Purification Technologies

http://www.reportlinker.com/p0316266/Downstream-Processing-in-Biopharmaceuticals---Increased-Demand-for-Biologics-Drives-Improvement-in-Cost--effective-Purification-Technologies.html

Downstream Processing in Biopharmaceuticals - Increased Demand for Biologics Drives Improvement in Cost -effective Purification Technologies

SummaryGBI Research's report, "Down Stream Processing in Biopharmaceuticals - Increased Demand for Biologics Drives Improvement in Cost-effective Purification Technologies", provides the key data and analyzes the major challenges and drivers for the downstream industry. The report also analyzes the strengths, weaknesses of and opportunities for the stakeholders in the downstream processing of biopharmaceuticals. The report also discusses the key market drivers and barriers for the growth of biomanufacturing in the pharmaceutical and biotech industry. The report is based on proprietary databases, primary and secondary research and in-house analysis by GBI Research's team of industry experts to provide a comprehensive view of the Down Stream Processing in Biopharmaceuticals.

ScopeThe scope of this report includes:

- Opportunities and challenges for manufacturers of Biopharmaceuticals in the pharmaceuticals industry

- Market revenues and forecasts for Down Stream Processing in the global pharmaceutical industry from 2009 to 2016.

- The key geographies including the US, Europe, Japan and Emerging Hotspots such as India, Singapore and China.

- Downstream bioprocess involves detailed technological development and possible development in near future.

- Technology trends in downstream bioprocess that shape the biomanufacturing industry

- Qualitative analysis of the market drivers, barriers, future outlook and challenges for the downstream bioprocess.

- Analysis of competitive landscape and the leading market players.

Reasons to buy- Formulate strategies to increase your company's growth by understanding the new growth opportunities in the downstream market.

- Work around the technology hurdles by identifying the key trends shaping and driving the market for downstream bioprocess.

- Differentiate yourself from competitors and develop new solutions for the biomanufacturing industry by understanding the current competitive landscape and how it is evolving to meet the increasing demands

- Draft efficient strategies by understanding best practices, identifying key winners and losers and who is best positioned to take advantage of the emerging market opportunities

1 Table of Contents 3

1.1 List of Tables 5

1.2 List of Figures 6

2 Downstream Processing: Introduction 8

2.1 GBI Research Report Guidance 8

3 Downstream Processing – Market Overview 9

3.1 Overview of Biopharmaceuticals 9

3.1.1 Cytokines 9

3.1.2 Enzymes 9

3.1.3 Hormones 9

3.1.4 Clotting Factors 9

3.1.5 Vaccines 10

3.1.6 Monoclonal Antibodies 10

3.1.7 Cell Therapies 10

3.1.8 Antisense Drugs 10

3.1.9 Peptide Therapeutics 10

3.2 Overview of Downstream Processing in Biopharmaceuticals 12

3.2.1 A Typical Downstream Processing: 13

3.2.2 Major Check Point during Down Stream Processing 14

3.3 Overview of Downstream Industry 15

4 Downstream Processing : Role of Downstream Processing in the Biopharmaceutical Industry 16

4.1 Comparison of Upstream Processing and Downstream Processing 18

4.2 Major Reagents, Reagent Suppliers and Reagent Market Related To Downstream Processing 19

4.2.1 Major Reagents 19

4.2.2 Reagent Suppliers 20

4.2.3 Reagent Market 22

4.3 Major Equipment Suppliers 26

5 Downstream Processing: Downstream Processing Market for CMOs 27

5.1 Global CMO Market Overview 27

5.2 CMO Biopharmaceuticals Market Characterization 27

5.3 CMO Market Size for Downstream Processing 29

6 Downstream Processing : Challenges and Unmet Needs in Downstream Bioprocess 30

6.1 Challenges 30

6.1.1 Chromatographic Capture 30

6.1.2 Reducing the Purification Steps 30

6.1.3 Titer increment /Capacity Bottleneck 31

6.1.4 Virus Clearances 31

6.1.5 Scaling –Up 31

6.2 Unmet Needs 32

6.2.1 Unmet Medical Needs 32

6.2.2 Realistic Achievement of Economies of Scale 33

6.2.3 Technological Development of Disposables at Large Scale 34

6.2.4 Reagent Cost and Their Effectiveness 35

7 Downstream Processing : Emerging Technologies and their Implication 36

7.1 Disposable Technology / Single Use Technology 36

7.1.1 Use of Single Use Technology in Downstream Operations 39

7.1.2 Major Benefits of Single use Technology 40

7.1.3 Major Challenges in Single Use Technology 41

7.1.4 Some Recent Products Developed By Major Firms 42

7.2 Membrane Chromatography 42

7.3 Multi-Column Chromatography 44

7.3.1 Advantages 44

7.3.2 Drawbacks 44

7.3.3 Applications 45

7.4 Aqueous Two Phase System 45

7.5 Tangential Flow Filtration 45

7.5.1 Tangential Flow Filtration Applications 46

7.5.2 Few Products Developed By Major Firms 47

7.6 Monoliths 47

7.7 Expanded-Bed Adsorption (EBA) Chromatography 47

7.7.1 Applications 48

7.8 Mixed-Mode Chromatography 48

8 Downstream Processing : Industry Analysis 50

8.1 Key Drivers and Restraints 50

8.1.1 Key Drivers of Downstream Processing Market 50

8.1.2 Key Restraints of Downstream Processing Market 51

8.2 Porter Five Forces Model for Industry Analysis 52

8.3 Impact of Environmental Factors on the Industry 55

8.3.1 International Economy Impact 55

8.3.2 The Natural Environment Impact 55

8.3.3 Technological Impact 55

8.3.4 Political or Governmental Impact 55

8.3.5 Demographic Structure 56

8.3.6 Social Structure 56

8.4 Major Events and Their Impact Analysis 56

9 Downstream Processing: Competitive Landscape 57

9.1 Market Dynamics of Downstream Processing and Impact 57

9.1.1 Market Structure 57

9.1.2 Competitive Analysis of Major CMO Firms 58

9.1.3 Competitive Analysis of Equipment and Reagent Industry 59

9.2 Key Equipment Players 60

9.2.1 Pall Corporation 60

9.2.2 Milipore 63

9.2.3 Sartorius 66

9.2.4 3M Purification Inc. 69

9.3 Key Reagent Players 71

9.3.1 Life Technologies 71

9.3.2 Sigma Aldrich 74

9.3.3 SWOT Analysis 75

9.3.4 M&A Deals 75

9.4 Key CMO Players 77

9.4.1 Lonza 77

9.4.2 Boehringer Ingelheim 80

9.4.3 SWOT Analysis 81

9.4.4 Avecia Biotechnology 83

9.4.5 Diosynth Biotechnology 85

10 Downstream Processing : Appendix 88

10.1 Market Definitions 88

10.2 Abbreviations 88

10.3 Research Methodology 89

10.3.1 Coverage 89

10.3.2 Secondary Research 89

10.3.3 Primary Research 89

10.3.4 Expert Panel Validation 90

10.4 Contact Us 90

10.5 Disclaimer 90

10.6 Sources 91

1.1 List of TablesTable 1: Downstream Processing, Comparison of Upstream and Downstream Process, 2009 18

Table 2: Downstream Processing, Reagent Suppliers, 2009 21

Table 3: Downstream Processing, Comparison of Mammalian and Microbial Culture, 2009 23

Table 4: Downstream Processing, Equipment Suppliers, 2009 26

Table 5: Downstream Processing, Types of Single Use Technologies and Vendors, 2009 38

Table 6: Downstream Processing, Key Equipment Players, Pall Corporation, Major M&A Deals, 2005-2009 62

Table 7: Downstream Processing, Key Equipment Players, Milipore, Major M&A Deals, 2005-2009 65

Table 8: Downstream Processing, Key Equipment Players, Sartorius, Major M&A Deals, 2005-2009 68

Table 9: Downstream Processing, Key Equipment Players, 3M, Major M&A Deals, 2005-2009 70

Table 10: Downstream Processing, Key Reagent Players, Life Technologies, Major M&A Deals, 2005-2009 73

Table 11: Downstream Processing, Key Reagent Players, Sigma Aldrich, Major M&A Deals, 2005-2009 76

Table 12: Downstream Processing, Key CMO Players, Lonza, Major M&A Deals, 2005-2009 79

Table 13: Downstream Processing, Key CMO Players, Boehringer Ingelheim, Major M&A Deals, 2005-2009 82

Table 14: Downstream Processing, Key Players, Avecia, Major M&A Deals, 2004-2009 85

Table 15: Downstream Processing, Key CMO Players, Diosynth Biotechnology, Major M&A Deals, 2005-09 87

1.2 List of FiguresFigure 1: Downstream Processing, Biopharmaceutical Types, 2009 9

Figure 2: Downstream Processing, Overview of General Drug Development Process, 2009 12

Figure 3: Downstream Processing, Technologies Employed Along with Steps, 2009 13

Figure 4: Downstream Processing, Changing Distribution of Cost along with Yield Increment, 2009 16

Figure 5: Downstream Processing, Yield Percentage v/s Number of Purification Steps, 2009 17

Figure 6: Downstream Processing, Cost Breakups of Upstream and Downstream Process, 2009 18

Figure 7: Downstream Processing, Total Reagent Market for Downstream Processing, Revenue ($m), 2009-2016 22

Figure 8: Downstream Processing, CMOs Reagent Market for Mammalian Capacity, Revenue ($m) 2009-2016 23

Figure 9: Downstream Processing, CMOs Reagent Market for Microbial Capacity, Revenue ($m) 2009-2016 24

Figure 10: Downstream Processing, In-house Reagent Market for Mammalian Capacity, Revenue ($m) 2009-2016 25

Figure 11: Downstream Processing, In-house Reagent Market for Microbial Capacity, Revenue ($m) 2009-2016 25

Figure 12: Downstream Processing, CMO Biopharmaceutical Market, Revenue ($bn), 2007-2016 28

Figure 13: Downstream Processing, Downstream Process Market For CMOs, Revenue ($bn), 2007-2016 29

Figure 14: Downstream Processing, Challenges, 2009 30

Figure 15: Downstream Processing, Unmet Medical Needs, 2009 32

Figure 16: Downstream Processing, Unmet Achievement of Economies of Scale, 2009 33

Figure 17: Downstream Processing, Unmet Technological Advancement, 2009 34

Figure 18: Downstream Processing, Unmet Reagent Cost Structure, 2009 35

Figure 19: Downstream Processing, Emerging Technologies and their Likely Adaptation, 2009 36

Figure 20: Downstream Processing, Single Use Technologies Benefits, 2009 40

Figure 21: Downstream Processing, Single Use Technologies Challenges, 2009 41

Figure 22: Downstream Processing, Industry Analysis, Key Drivers and Restraints, 2009 51

Figure 23: Downstream Processing, Industry Analysis, Porter Five Forces Model, 2009 52

Figure 24: Downstream Processing, Industry Analysis, Environmental Factors and Impact, 2009 55

Figure 25: Downstream Processing, Industry Analysis, Major Market Events and their Impact, 2009 56

Figure 26: Downstream Processing, Industry Analysis, Market Dynamics, 2009 58

Figure 27: Downstream Processing, Industry Analysis, Competitive Analysis of Major CMOs, 2009 58

Figure 28: Downstream Processing, Industry Analysis, Competitive Analysis of Major Equipment / Reagent Players, 2009 59

Figure 29: Downstream Processing, Key Equipment Players, Business Overview, Pall Corporation, 2009 60

Figure 30: Downstream Processing, Key Equipment Players, SWOT Analysis, Pall Corporation, 2009 61

Figure 31: Downstream Processing, Key Equipment Players, Business Overview, Milipore, 2009 63

Figure 32: Downstream Processing, Key Equipment Players, SWOT Analysis, Milipore, 2009 64

Figure 33: Downstream Processing, Key Equipment Players, Business Overview, Sartorius, 2009 66

Figure 34: Downstream Processing, Key Equipment Players, SWOT Analysis, Sartorius, 2009 67

Figure 35: Downstream Processing, Key Equipment Players, Business Overview, 3M Purification Inc. , 2009 69

Figure 36: Downstream Processing, Key Equipment Players, SWOT Analysis, 3M Purification Inc. , 2009 70

Figure 37: Downstream Processing, Key Reagent Players, Business Overview, Life Technologies, 2009 71

Figure 38: Downstream Processing, Key Reagent Players, SWOT Analysis, Life Technologies, 2009 72

Figure 39: Downstream Processing, Key Reagent Players, Business Overview, Sigma-Aldrich, 2009 74

Figure 40: Downstream Processing, Key Reagent Players, SWOT Analysis, Sigma-Aldrich, 2009 75

Figure 41: Downstream Processing, Key CMO Players, Business Overview, Lonza, 2009 77

Figure 42: Downstream Processing, Key CMO Players, SWOT Analysis, Lonza, 2009 78

Figure 43: Downstream Processing, Key CMO Players, Business Overview, Boehringer Ingelheim, 2009 80

Figure 44: Downstream Processing, Key CMO Players, SWOT Analysis, Boehringer Ingelheim, 2009 81

Figure 45: Downstream Processing, Key CMO Players, Business Overview, Avecia , 2009 83

Figure 46: Downstream Processing, Key CMO Players, SWOT Analysis, Avecia, 2009 84

Figure 47: Downstream Processing, Key CMO Players, Business Overview, Diosynth Biotechnology, 2009 86

Figure 48: Downstream Processing, Key CMO Players, SWOT Analysis, Diosynth Biotechnology, 2009 87

Companies mentioned Pall Corporation

Milipore

Sartorius

3M Purification Inc.

To order this report:Biopharmaceutical Industry: Downstream Processing in Biopharmaceuticals - Increased Demand for Biologics Drives Improvement in Cost -effective Purification Technologies

Biopharmaceutical Business News

More  Market Research Report

Check our  Company Profile, SWOT and Revenue Analysis!Nicolas BombourgReportlinkerEmail: nbo@reportlinker.comUS: (805)652-2626Intl: +1 805-652-2626
'/>"/>

SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Reportlinker Adds Infectious Disease Molecular Diagnostic Testing
2. Reportlinker Adds Smart Glass: Technologies and Global Markets Report
3. Reportlinker Adds Synthetic Biology: Emerging Global Markets Report
4. Reportlinker Adds Proteomics: Technologies and Global Markets Report
5. Reportlinker Adds Nanomedicine Report
6. Reportlinker Adds Small Molecule Kinase Inhibitors Report
7. Reportlinker Adds Nanoporous Materials Report
8. Reportlinker Adds Membrane Bioreactors Report
9. Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement
10. Reportlinker Adds High-Tech Patient Monitoring Systems Markets (Remote and Wireless Systems, Data Processing, EMR Data Transfer) Report
11. Reportlinker Adds In Vitro Diagnostics in a Recession: IVD Market Forecasts, Analysis and Success Strategies Report
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... A person commits a crime, and the detective ... the criminal down. An outbreak of foodborne illness ... (FDA) uses DNA evidence to track down the bacteria that ... It,s not. The FDA has increasingly used a complex, cutting-edge ... illnesses. Put as simply as possible, whole genome sequencing is ...
(Date:6/23/2016)... MONICA, Calif. , June 23, 2016  The Prostate Cancer Foundation ... pioneer increasingly precise treatments and faster cures for prostate cancer. Members of the ... institutions across 15 countries. Read More About the Class ... ... ...
(Date:6/23/2016)... ... 2016 , ... Supplyframe, the Industry Network for electronics hardware ... . Located in Pasadena, Calif., the Design Lab’s mission is to bring together ... built and brought to market. , The Design Lab is Supplyframe’s physical representation ...
(Date:6/23/2016)... LOUISVILLE, Ky. , June 23, 2016 /PRNewswire/ ... from two Phase 1 clinical trials of its ... double-blind, placebo-controlled, single and multiple ascending dose studies ... and pharmacodynamics (PD) of subcutaneous injection in healthy ... APL-2 subcutaneously (SC) either as a single dose ...
Breaking Biology Technology:
(Date:6/7/2016)... , June 7, 2016  Syngrafii Inc. and ... business relationship that includes integrating Syngrafii,s patented LongPen™ ... project. This collaboration will result in greater convenience ... credit union, while maintaining existing document workflow and ... ...
(Date:6/1/2016)... YORK , June 1, 2016 ... Technology in Election Administration and Criminal Identification to Boost ... to a recently released TechSci Research report, " Global ... By Region, Competition Forecast and Opportunities, 2011 - 2021", ... 24.8 billion by 2021, on account of growing security ...
(Date:5/9/2016)... 2016 Elevay is currently known ... freedom for high net worth professionals seeking travel for ... connected world, there is still no substitute for a ... sealing your deal with a firm handshake. This is ... advantage of citizenship via investment programs like those offered ...
Breaking Biology News(10 mins):